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Purpose: Degenerative retinal diseases are characterized by inflammation and microglial activation. The nonpsychoactive
cannabinoid, cannabidiol (CBD), is an anti-inflammatory in models of diabetes and glaucoma. However, the cellular and
molecular mechanisms are largely unknown. We tested the hypothesis that retinal inflammation and microglia activation
are initiated and sustained by oxidative stress and p38 mitogen-activated protein kinase (MAPK) activation, and that CBD
reduces inflammation by blocking these processes.
Methods: Microglial cells were isolated from retinas of newborn rats. Tumor necrosis factor (TNF)-α levels were
estimated with ELISA. Nitric oxide (NO) was determined with a NO analyzer. Superoxide anion levels were determined
by the chemiluminescence of luminol derivative. Reactive oxygen species (ROS) was estimated by measuring the cellular
oxidation products of 2’, 7’-dichlorofluorescin diacetate.
Results: In retinal microglial cells, treatment with lipopolysaccharide (LPS) induced immediate NADPH oxidase-
generated ROS. This was followed by p38 MAPK activation and resulted in a time-dependent increase in TNF-α
production. At a later phase, LPS induced NO, ROS, and p38 MAPK activation that peaked at 2-6 h and was accompanied
by morphological change of microglia. Treatment with 1 μM CBD inhibited ROS formation and p38 MAPK activation,
NO and TNF-α formation, and maintained cell morphology. In addition, LPS-treated rat retinas showed an accumulation
of macrophages and activated microglia, significant levels of ROS and nitrotyrosine, activation of p38 MAPK, and
neuronal apoptosis. These effects were blocked by treatment with 5 mg/kg CBD.
Conclusions:  Retinal  inflammation  and  degeneration  in  uveitis  are  caused  by  oxidative  stress.  CBD  exerts  anti-
inflammatory and neuroprotective effects by a mechanism that involves blocking oxidative stress and activation of p38
MAPK and microglia.
Degenerative retinal diseases such as uveitis, glaucoma,
macular degeneration, and diabetic retinopathy all involve
inflammation with activated microglia [1]. Inflammation is an
active defense reaction against diverse insults, designed to
remove  or  inactivate  noxious  agents  and  to  inhibit  their
detrimental  effects.  Although  inflammation  serves  as  a
protective function in controlling infections and promoting
tissue repair, it can also cause tissue damage and disease.
Following brain injury, inflammation occurs in response to
glutamate, reactive oxygen species (ROS), nitric oxide (NO),
and  cytokines  including  tissue  necrosis  factor  (TNF)-α,
released from activated microglia or macrophage, leading to
neurodegeneration [2].
To understand how inflammation affects retinal function
in degenerative retinal diseases, it is necessary to examine the
processes and signaling pathways during inflammation with
in vivo and in vitro models. Endotoxin-induced uveitis (EIU)
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in rodents is an in vivo model for acute ocular inflammation
induced by systemic or local injection of lipopolysaccharide
(LPS)  [3,4].  EIU  is  characterized  by  a  breakdown  of  the
blood–ocular barrier [2] with inflammatory cell infiltration
involving the anterior and posterior segments of the eye [4]
and accelerated death of retinal ganglion cells [5]. To further
elucidate the molecular events of retinal inflammation, LPS-
activated cultured retinal microglial cells have been used as a
model to simulate neuroinflammation [6]. The p38 mitogen-
activated  protein  kinase  (p38  MAPK),  a  stress-activated
serine/threonine protein kinase, is a downstream target of
proinflammatory cytokines and oxidative stress. In addition,
activation of p38 MAPK has been also implicated in both
induction  of  inflammatory  mediators  and  transcription-
independent effects such as induction of actin reorganization
and cellular motility [7-9].
The  neuroprotective  effects  of  a  nonpsychoactive
cannabinoid, cannabidiol (CBD), are largely mediated by its
ability to scavenge ROS [10]. We have shown that CBD
reduces diabetes- and glutamate-induced ROS formation, p38
MAPK  activation,  blood–retina  barrier  breakdown,  and
retinal degeneration [11,12]. Cannabinoids are known to serve
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2190as an anti-inflammatory by modulating the activity of cerebral
microglia during inflammation [13]. To date, however, the
cellular and molecular mechanism by which CBD reduces
inflammation in degenerative retinal diseases is still unclear.
In  the  present  study,  we  test  the  hypothesis  that  retinal
inflammation  and  degeneration  are  initiated  by  oxidative
stress,  which  activates  p38  MAPK,  and  causes  cytokine
release that eventually leads to the activation of microglial
cells  and  neurodegeneration.  We  also  show  that  the
neuroprotective  and  anti-inflammatory  effects  of  CBD
involve reducing oxidative stress and modulating p38 MAPK
activation in EIU model and LPS-treated retinal microglial
cells.
METHODS
Animal preparation and experimental design: This study used
inbred male, 8-10-week-old Sprague-Dawley (SD) rats, each
weighing approximately 250 g (Charles River, Durham, NC).
The  animals  were  treated  in  accordance  with  the  ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research. Three sets of animals were prepared for a total of
72 rats to study the effect of CBD on EIU. The CBD-treated
control or uveitis group received one intraperitoneal injection
of CBD (National Institute of Drug Abuse, Research Triangle
Park, NC) at 5 mg/kg bodyweight in a 0.25 ml solution that
contained 1 part alcohol to 1 part Cremophor EL to 18 parts
Ringer solution. This dose was selected based on previous
studies  showing  maximum  protection  of  CBD  [11,12].
Control groups received vehicle injections. One hour after
CBD  or  vehicle  injection,  rats  were  anesthetized  with  an
intraperitoneal  injection  of  40  mg/kg  Nembutal  (Abbott
Laboratories, Abbott Park, IL). LPS (Sigma, St. Louis, MO),
from Salmonella typhimurium prepared in sterile saline at
1  mg/ml,  was  given  at  0.35  mg/kg  bodyweight  [13,14].
Experiments were performed 24 h after LPS injection, using
3–6 rats for each group in each experiment.
Immunohistochemistry:  Immunohistochemistry  was
performed to identify macrophages or activated microglia on
the  flat-mounted  retinas  [14]  using  monoclonal  antibody
CD11b.  This  antibody  reacts  with  the  CR3  complement
receptor  expressed  on  monocytes,  granulocytes,
macrophages, dendritic cells, natural killer (NK) cells, and a
subset  of  lymphocytes.  Incubation  with  the  primary  and
Texas-red fluorescence-labeled secondary antibodies at 4 °C
was  performed  overnight.  Immunostained,  flat-mounted
retinas were placed on slides with the inner side of the retina
facing up, covered, and examined with confocal microscopy.
Primary  retinal  microglia  culture:  Microglial  cells  were
isolated  from  retinas  of  newborn  SD  rats  according  to  a
previous procedure [15], with minor modifications. Briefly,
retinas were dissected within 48 h from newborn SD rat pups.
Tissues were collected into 0.01 M PBS (0.01 M NaH2PO4/
Na2HPO4, 0.15 M NaCl, pH 7.4) and washed with ice-cold
0.01 M PBS, then digested with 0.125% trypsin for 3–5 min
before mixing with a 1:1 blend of DMEM and F12 medium
(Invitrogen,  Carlsbad,  CA)  containing  10%  fetal  bovine
serum  (FBS;  Atlanta  Biologicals,  Atlanta,  GA)  and  1%
penicillin/streptomycin  (Mediatech,  Herndon,  VA).  Retina
pieces were triturated by passing through a disposable pipette
several  times  until  cells  were  dispersed.  Cells  were  then
filtered through a 100 μm mesh, collected by centrifugation,
resuspended in culture medium, and plated onto T150 cell
culture flasks (Corning, Corning, NY) at a density of 2×105
cells/cm2. All cultures were maintained in a humidified CO2
incubator at 37 °C and 5% CO2 and fed on the third day, then
once  every  4  days.  After  2  weeks,  microglial  cells  were
harvested by shaking the flasks at 100 rpm for 1 h. The cell
suspension  was  centrifuged  and  the  detached  cells  were
replated in a 1:1 mixture of DMEM and F12 medium plus 10%
FBS overnight and then in serum-free, low-protein medium
(Cellgro  Complete  containing  0.1%  BSA;  Mediatech)  at
designated  densities  for  various  experiments.
Immunocytochemical studies showed that more than 95% of
the cultured cells stained positively for CD11b (Figure 1),
with staining localized to the cell membrane. Almost none of
these cells showed positive staining for glial fibrillary acidic
protein (GFAP), indicating that the majority of the isolated
cells  were  microglia  and  were  not  contaminated  with
astrocytes or Müller cells (data not shown).
Drug treatment effects on cultured microglial cells: Microglia
collected  from  culture  flasks  were  seeded  at  a  density  of
5×105 cells/well in 24 well tissue culture plates, or 1×105 cells/
well in 96 well plates. One day after seeding, the culture wells
were  washed  with  Cellgro  Complete  (Mediatech)  and
incubated in the same medium with various treatments. For
microglia treatment, LPS at the final concentration of 30 ng/
ml (Escherichia coli 0111:B4; Sigma) was added to each well
for  24  h.  CBD  (Cayman  Chemical,  Ann  Arbor,  MI)  was
dissolved in dimethyl sulfoxide (DMSO) as 30 mM stock
solution and used at a final concentration of 1 μM. Apocynin,
an  NADPH  oxidase  assembly  inhibitor,  was  dissolved  in
DMSO as 3M stock solution and a range of concentrations of
15,  100,  and  200  µM  was  used.  Thenoyltrifluoroacetone
(TTFA), an inhibitor of mitochondrial oxidase, was used at
15 μM. Finally, SB 203580, a specific inhibitor of p38 MAPK,
was supplied as a 1 mg/ml solution in DMSO and used at a
final concentration of 10 μM. At indicated time points, 50 μl
aliquots of incubation medium were taken and analyzed for
ROS, TNF-α, and NO. Cells were used for superoxide anion
assay by chemiluminescence. Also at each time point, cells
were washed, homogenized, and subjected to western analysis
as will be described.
Morphological  analysis  of  cultured  microglial  cells:
Microglia  collected  from  culture  flasks  were  seeded  at  a
density of 2×105 cells/chamber in 4 chambered slides. The
purity  of  the  microglial  cultures  and  their  morphological
responses to LPS and CBD treatments were ascertained using
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2191Figure 1. Cannabidiol prevents retinal
microglial  activation  or  macrophage
infiltration  and  inhibits  serum  and
retinal tumor necrosis factor release in
the  uveitic  rat.  A-E:  Confocal
micrographs of retina whole-mounts or
sections that show activated microglia
or infiltrated macrophages as stained by
the  microglia/macrophage-specific
marker  CD11b  and  by  Texas  red-  or
Oregon  green-conjugated  secondary
antibody. A: Normal rat.  B: Twenty-
four  h  after  lipopolysaccharide  (LPS)
injection.  C:  Cannabidiol  (CBD)-
pretreated  and  LPS-injected.  D:
Microglia  in  normal  eye  sections,
Oregon  green,  counter-stained  with
propidium iodide (red). E: Microglia in
normal  retinal  whole-mounts,  Oregon
green. F: Serum TNF-α levels in 3 rats,
24 h after LPS injection with or without
CBD  treatment  (mean±SEM;  asterisk
represents  that  it  is  significantly
different  when  compared  with  the
control at p<0.05). G: Retinal TNF-α
levels in 3 rats, 24 h after LPS injection
with or without CBD treatment (mean
±SEM;  asterisk  represents  that  it  is
significantly different when compared
with the control at p<0.05).
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2192immunocytochemical  staining  analysis  for  CD11b,  a
microglial marker, or for F-actin distribution using fluorescent
phallotoxins (Molecular Probes, Eugene, OR). The purity and
morphology  of  microglia  in  culture  was  examined  with
confocal microscopy.
Protein  extraction  and  western  blot  analysis:  Dissected
individual  rat  retinas  or  washed  cultured  cells  were
homogenized in a Mini-Bead beater with treated Ottawa sand
in  modified  RIPA  buffer  (Upstate,  Lake  Placid,  NY),
containing 50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1%
Nonidet P-40, 0.25% deoxycholate, supplemented with 40
mM  NaF,  2  mM  Na3VO4,  0.5  mM  phenylmethylsulfonyl
fluoride  and  1:100  (v/v)  of  proteinase  inhibitor  cocktail
(Sigma). Insoluble material was removed by centrifugation at
12,000x g at 4 °C for 30 min. Protein was determined by DC
Protein Assay (Bio-Rad, Hercules, CA). Antibodies for β-
actin  (Sigma),  phospho-p38  MAPK,  p38  MAPK,  and
caspase-3 were purchased from Cell Signaling Technology
(Beverly, MA). Protein of 50−100 μg was boiled in Laemmli
sample buffer, separated by SDS–PAGE on a 10% or gradient
gel  (4  to  20%;  Bio-Rad),  transferred  to  nitrocellulose
membrane  and  incubated  with  specific  antibodies.  The
primary  antibody  was  detected  using  a  horseradish
peroxidase-conjugated  goat  antirabbit  antibody  and  ECL
advanced  chemiluminescence  (Amersham  BioSciences,
Buckinghamshire, UK). Intensity of immunoreactivity was
measured by densitometry (n=3–5 in each group).
Enzyme-linked immunosorbent assay for TNF-α in culture
medium: TNF-α levels in rat serum or supernatants of culture
medium were estimated with ELISA kits (R&D, Minneapolis,
MN)  per  the  manufacturer’s  instructions.  Standards  and
samples were added and bound by the immobilized antibody.
Samples were washed by the washing solution provided in the
ELISA  kit,  and  an  enzyme-linked  polyclonal  antibody
specific for the cytokine was added to the wells followed by
a substrate solution, yielding a colored product. The intensity
of the color was measured at 450 nm. The sample levels were
calculated  from  a  standard  curve  and  were  corrected  for
protein concentration.
Nitric  oxide  measurement:  Nitrite  (NO2-),  the  stable
breakdown product of NO, was quantitatively reduced to NO
and could be quantified by a chemiluminescence detector after
reaction  with  ozone  in  an  NO  analyzer  (Sievers,  GE
Analytical Instruments, Boulder, CO). Briefly, medium of
cultured  microglial  cells  were  deproteinized,  and  samples
containing  NO2-  were  refluxed  in  glacial  acetic  acid
containing sodium iodide. The amount of NO generated was
calculated as the difference in basal and LPS-stimulated NO
levels.
Chemiluminescence:  The  superoxide  anion  levels  were
determined in the LPS-treated cells in the presence or absence
of 1 μM CBD, 15 μM apocynin (an NADPH oxidase assembly
inhibitor), 15 μM TTFA (a mitochondrial oxidase inhibitor),
or 100 U/ml superoxide anion dismutase. Cell medium in 96
well plates was replaced with 50 μl of Earle’s balanced salt
solution. An equal volume of the same solution containing
800 μM of highly sensitive luminol derivative L-012 (Pure
Chemical Industries, Osaka, Japan) [16] was added to each
well. Chemiluminescence was measured with a Synergy-2
plate reader (Bio-Tek Instruments, Winooski, VT).
Dichlorofluorescein  (DCF)  assay:  Dichlorofluorescein
(DCF)  is  the  oxidation  product  of  the  reagent  2’,7’-
dichlorofluorescin diacetate (H2DCFDA; Molecular Probes),
a marker of cellular oxidation by hydrogen peroxides and
peroxynitrite [17]. Briefly, a 5 mM solution of H2DCFDA was
prepared in absolute ethanol and stored under N2 at −20 °C,
in the dark. Earle’s balanced salt solution containing 5 μM
H2DCFDA was directly applied to and incubated with frozen
eye sections for 30 minutes in the dark at room temperature.
The sections were then washed with Earle’s balanced salt
solution [12]. The fluorescence of DCF was measured and
analyzed in eye sections or in cell lysates. The average retinal
fluorescence intensity (6 fields/retina) was analyzed using
fluorescence  microscopy  and  Ultra-View  morphometric
software  (Molecular  Devices,  Sunnyvale,  CA).  The
fluorescence  of  the  cell  lysates  was  determined  using  a
spectrofluorometer  (Synergy-2  plate  reader;  BioTek
Instruments Inc, Winooski, VT) with 488 nm excitation and
530 nm emission.
Measurement  of  retinal  nitrotyrosine:  Nitrotyrosine
immunoreactivity  was  measured  as  an  indicator  for
peroxynitrite formation. The distribution of nitrotyrosine in
frozen eye sections was analyzed using immunolocalization
techniques  with  confocal  microscopy  using  antibodies
specific for nitrotyrosine [12]. Frozen eye sections were fixed
with 4% paraformaldehyde then reacted with a polyclonal
rabbit  antinitrotyrosine  antibody  (Upstate  Biotechnology)
followed  by  Oregon  green-conjugated  goat  antirabbit
antibody (Molecular Probes). Data (6 fields/retina; n=6 in
each group) were analyzed using fluorescence microscopy
and Ultra View Morphometric software to quantify intensity
of immunostaining.
Terminal  dUTP  nick  end-labeling  (TUNEL):  Eyes  were
mounted in optimal cutting temperature (OCT) and 10 μm
sections were collected and stored at −80 °C. TUNEL was
performed in these frozen sections using the Apop TAG in
situ  cell  death  detection  kit  (TUNEL-FITC;  Chemicon
International) [11].
Data analysis: The results are expressed as mean ±SEM.
Differences among experimental groups were evaluated by
ANOVA, and the significance of differences between groups
was  assessed  by  the  posthoc  test  (Fisher’s  PLSD)  when
indicated. Significance was defined as p<0.05.
RESULTS
CBD inhibits retinal microglial activation in uveitic rats: We
examined  the  retinas  from  LPS-treated  rats  to  test  the
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macrophages are present in the retina during inflammation.
Serum and retinas were collected for TNF-α measurement 24
h  after  footpad  injection  of  LPS.  The  retinas  were  also
examined  by  immunofluorescence  using  an  antibody  for
CD11b, a marker for microglia or macrophages. As shown in
Figure 2A, in the normal, untreated retina, the microglia,
mainly localized in the ganglion and inner plexiform layers,
appear to have long, thin processes. There were few CD11b-
positive round cells attached to the retinal blood vessels. Upon
LPS treatment, there was a dramatic increase in the number
and intensity of the CD11b-positive cells in the flat-mounted
retina. CD11b+ cells that attached to the retinal blood vessels
began  to  migrate  into  the  retina.  At  24  h,  we  frequently
observed attachment of an increasing number of round cells
to the retinal blood vessels, accompanied by infiltration of
some  cells  into  the  retina  and  occasionally  by  focal
accumulation of these cells around the blood vessels. We
found few CD11b+ round cells in 5 mg/kg CBD-pretreated
uveitic rats.
In response to LPS challenge, the immune cells, including
macrophages, released proinflammatory cytokines to amplify
the inflammation reactions, both locally and systematically.
As shown in Figure 2B,C, the serum or retinal levels of TNF-
α were 30–40% higher than control 24 h after LPS injection.
In LPS-treated rats that were pretreated with CBD, the rise of
TNF-α was prevented.
CBD reduces morphological changes in retinal microglial
cells: Activated microglia has been reported to play a key role
in causing inflammation and neurodegeneration in uveitis and
Figure 2. Effects of cannabidiol (CBD) on lipopolysaccharide (LPS)-induced morphological changes in rat retinal microglial cells. Confocal
micrographs were made of cells identified by microglial- and macrophage-specific marker CD11b followed by Oregon green-conjugated
secondary antibody. Cell nuclei were counter-stained by propidium iodide. A: Cells were cultured in serum-free medium for 12 h. B: Cells
were treated with 30 ng/ml lipopolysaccharide in serum-free medium for 12 h. C: Cells were cannabidiol (CBD, 1 μM)-pretreated and
lipopolysaccharide-treated for 12 h. D-F: Cells similarly treated were also stained with fluorescent phallotoxins for Filamentous actin
distribution and cellular morphology. Scale bar represents 20 μm.
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2194other models [2]. Therefore, we examined the behavior of
cultured  rat  retinal  microglial  cells  in  response  to  LPS
treatment to determine how inflammation occurs, and how
CBD  blocks  this  event.  Rat  retinal  microglial  cells  were
prepared  according  to  an  established  protocol  [15].
Immunocytochemical studies showed that the prepared cells
express CD11b (Figure 2A). Treatment with 30 ng/ml LPS
induced  microglia  activation  as  indicated  by  enhanced
expression of CD11b and morphological changes (Figure 2B).
These effects were prevented by pretreatment of cells with 1
μM CBD (Figure 2C). The activation effect of LPS and the
prevention effect of CBD in microglial cells were further
confirmed by the increased expression and re-arrangement of
F-actin, as compared with the control (Figure 2D-F).
CBD prevents TNF-α increase in retinal microglial cells: To
test  the  hypothesis  that  LPS  treatment  induces  TNF-α
production, we treated retinal microglial cells with LPS. We
Figure  3.  Cannabidiol  reduces  tumor  necrosis  factor-α  levels  in
lipopolysaccharide-treated  rat  retinal  microglial  cells.  Culture
medium of retinal microglial cells were collected at different time
points  after  lipopolysaccharide  (LPS)  treatment  and  assayed  for
tumor necrosis factor-α (TNF-α) with ELISA. A: TNF-α levels were
measured at different times in LPS-treated microglial cells and were
compared with the control. B: TNF-α levels were compared in the
presence or absence of 1 μM cannabidiol (CBD). Data shown is the
mean of 6 samples measured at 6 h±SEM. Asterisk represents that it
is significantly different when compared with the 0 time or control
at p<0.05.
then collected culture medium at 5, 15, 20, and 30 min and 1,
2, 4, 6, 12, and 24 h after treatment and assayed for TNF-α.
In the medium of LPS-treated cultures, levels of TNF-α began
to increase significantly at or after 4 h of LPS treatment,
peaking at 6 h, then leveled off within the 24 h period (Figure
3A). Early treatment (0–30 min) with LPS did not induce
TNF-a production in microglial cells (data not shown). The
levels  of  TNF-α  in  control  culture  medium  without  LPS
treatment did not change throughout the experimental period
(Figure 3A and data not shown). We next evaluated the effects
of CBD in reducing TNF-α production. As shown in Figure
3B, pretreatment with 1 µM CBD blocked TNF-α production
after 6 h of LPS treatment in retinal microglial cells.
CBD  blocks  superoxide  formation  via  NADPH  oxidase
inhibition: It is known that many stress factors, including
oxidative  stress,  lead  to  inflammation.  Therefore,  we
determined  ROS  formation  after  LPS  treatment  in  the
Figure  4.  Cannabidiol  blocks  lipopolysaccharide-induced  early
superoxide  formation  A:  In  microglial  cells  treated  with
lipopolysaccharides (LPS), maximal reactive oxygen species (ROS)
formation measured by chemiluminescence assay was observed at
30 min. Cannabidiol (CBD) reduced ROS formation during this
period.  Data  shown  is  the  mean  of  5  samples±SEM;  Asterisk
represents that it is significantly different when compared with CBD-
treated at p<0.01. B: Comparison of ROS formation measured by
chemiluminescence assay on microglial cells pretreated with CBD,
apocynin, TTFA, or PEG-SOD and treated with vehicle (control) or
LPS. Results suggested that superoxide component of ROS in LPS-
treated retinal microglia is generated from NADPH oxidase. Data
shown is the mean of 6 samples measured at 30 min±SEM; Asterisk
represents that it is significantly different when compared with CBD-
treated at p<0.01.
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showed  that  stimulation  of  the  cells  with  LPS  caused
immediate  and  significant  increases  in  superoxide  anion
formation (0–30 min), gradually decreasing at 60 min (Figure
4A). Pretreatment of microglial cells with CBD significantly
reduced ROS formation during this period. To determine the
source of superoxide anion formation, we treated microglia
cells  were  pretreated  with  15  μM  apocynin  (a  specific
NADPH  oxidase  assembly  inhibitor),  15  μM  TTFA  (a
mitochondrial  oxidase  inhibitor),  or  100  U/ml  superoxide
anion dismutase (SOD). Chemiluminescence assay showed
that  stimulation  of  the  cells  with  LPS  caused  about  50%
increase  in  the  ROS  formation  at  30  min  (Figure  4B).
Apocynin  at  15  μM  significantly  reduced  LPS-induced
superoxide  anion  formation  similar  to  CBD  effects.  In
contrast, inhibiting mitochondrial oxidase with 15 μM TTFA
did not alter LPS-induced superoxide anion formation. While
CBD  or  apocynin  did  not  alter  superoxide  levels  in  the
Figure 5. Oxidative stress and p38 MAPK activation are causally
related and are involved in release of tumor necrosis factor-α. A:
Lipopolysaccharide (LPS) caused a time-dependent activation of p38
MAPK with highest activation at 60 min. Cannabidiol (CBD; 1 μM)
or  apocynin  (200  μM)  reduced  the  activation  of  p38  MAPK
(phospho-p38) throughout the 60 min. Data shown is the mean of 2-3
experiments±SEM;  asterisk  represents  that  it  is  significantly
different  when  compared  with  the  controls  at  p<0.05.  B:
Pretreatment of microglial cells with apocynin (200 μM) or the p38
MAPK inhibitor, SB203580 (10 µM), inhibited the LPS-induced
release of tumor necrosis factor-α (TNF-α). Treatment with both
apocynin and SB203580 did not further decrease the release of TNF-
α.  Data  shown  is  the  mean  of  4-8  experiments±SEM.  Asterisk
represents that it is significantly different at p<0.001 when compared
with vehicle control or with apocynin-treated and SB203580-treated
control;  hash  mark  represents  that  it  is  significantly  different  at
p<0.05 when compared with LPS alone.
controls, treatment with TTFA increased superoxide levels in
the control. This may be due to a nonspecific effect of TTFA.
The  signal  was  blocked  completely  by  SOD,  indicating
specificity of the detection of superoxide anion.
P38 MAPK mediates LPS-induced release of TNF-α in retinal
microglial cells: Cytokine release has been reported to be
mediated by p38 MAPK or oxidative stress in macrophages
[7]. Immunoblot assays showed that stimulation of the cells
with LPS caused minimal activation of p38 MAPK at 15 min,
slowly increased at 30 min, and further increased at 60 min
(Figure 5A). Pretreatment of CBD at 1 μM or apocynin at
200 μM blocked p38 MAPK activation in response to LPS.
These  results  suggest  that  in  response  to  LPS  treatment,
oxidative  stress  causes  p38  MAPK  activation  in  retinal
microglial cells. To understand the regulation of cytokine
release in LPS-treated retinal microglial cells, we sought to
determine whether the release of TNF-α was mediated by
oxidative stress as well as p38 MAPK. The roles of NADPH
oxidase and p38 MAPK were examined by using apocynin
and the p38 MAPK inhibitor SB203580, respectively [18].
Pretreatment of rat retinal microglial cells with SB203580 at
10 μM significantly decreased the LPS-induced release of
TNF-α (Figure 5B). Pretreatment with apocynin at 200 μM,
although  less  effective  as  compared  with  SB203580,  also
significantly decreased the LPS-induced release of TNF-α.
Pretreatment  with  both  apocynin  and  SB203580  did  not
further decrease TNF-α beyond the effect of SB203580 alone,
suggesting that the effects of oxidative stress and p38 MAPK
activation are related, and not independent, events.
Treatment with both apocynin and SB203580 did not
alter  TNF-α  levels  in  the  controls.  In  the  same  study,
pretreatment with CBD at 1 μM almost completely blocked
the release of TNF-α (Figure 3 B), suggesting that CBD has a
potent effect in blocking oxidative stress and p38 MAPK
activation.
CBD inhibits NO, peroxynitrite, and p38 MAPK in microglial
cells: To study the effects of LPS and CBD on the release of
NO, we collected culture medium at 5, 15, 20, and 30 min and
1, 2, 4, 6, 12, and 24 h after LPS treatment. NO levels in the
culture medium were determined using an NO analyzer. The
levels of NO in control culture medium without LPS treatment
did not change throughout the experimental period. In the
LPS-treated  cultures,  LPS-induced  activation  of  microglia
involved a significant late increase in the NO level in culture
medium (Figure 6A). The increment of NO levels became
significant only after 6 h of LPS treatment and continued for
12 h. LPS-treated rat retinal microglial cells pretreated with
CBD  for  60  min  at  1  µM  reduced  NO  at  6  or  12  h.
Peroxynitrite, the combination product from superoxide and
NO, increased oxidative and nitrative stresses in the cells. To
study  the  effects  of  LPS  and  CBD  on  the  oxidative  and
nitrative stresses, we collected culture medium at various time
points after LPS treatment for fluorescence measurement of
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2196DCF (Figure 6B). LPS induced DCF fluorescence as early as
Figure  6.  Cannabidiol  reduces  lipopolysaccharide-induced  late
increases of nitric oxide and peroxynitrite and p38 MAPK activation.
A:  Lipopolysaccharide  (LPS)  caused  maximal  increase  in  nitric
oxide (NO) formation at 6 h and after. Cannabidiol (CBD) reduced
NO formation during this period. Data shown is the mean of 4-6
experiments±SEM.  Asterisk  represents  that  it  is  significantly
different at p<0.05 when compared with 0 time. B: LPS caused
peroxynitrite formation as early as 15 min, followed by a further
increase at 6-12 h. CBD reduced peroxynitrite formation during this
period. Data shown is the mean of 6 experiments±SEM; asterisk
represents that it is significantly different at p<0.005 as compared to
CBD-treated. C: LPS treatment of microglial cells for 0-12 h induced
a second peak of phospho-p38 MAPK at 2-6 h. CBD significantly
reduced p38 MAPK activation level during this period. Data shown
is the mean of 3 experiments±SEM; asterisk represents that it is
significantly different at p<0.05 when compared with 0 time.
15 min, followed by a further increase at a later phase of 6-12
h. CBD at 1 µM reduced DCF fluorescence during this period.
We next evaluated the effects of LPS on activation of p38
MAPK in the late phase (at 2, 6, or 12 h). Immunoblotting of
phospho-p38 MAPK showed a time-dependent activation that
peaked at 2-6 h in rat retinal microglial cells. Pretreatment
with 1 μM CBD significantly reduced it (Figure 6C). LPS
treatment did not affect the levels of p38 MAPK or actin
proteins (data not shown). Together, these results suggest that
LPS induces a second phase of increased oxidative stress and
p38 MAPK activation, which coincides with cytokine release
and morphological changes with F-actin rearrangement in the
microglial cells (Figure 2E).
CBD reduces oxidative and nitrative stresses in the uveitic
retina: To elucidate the mechanism and the consequences of
inflammation in the uveitic retina and the neuroprotective
effects of CBD, we determined the oxidative and nitrative
stresses in the rat retina in the presence or absence of CBD 24
h after the injection of LPS. As shown in Figure 7A, images
from  uveitic  retinas  of  6  rats  showed  increased  DCF
fluorescence in the inner and outer plexiform and the outer
segment  layers.  Quantitative  analysis  showed  a  1.5  fold
increase (p<0.05) in the fluorescence intensity in the uveitic
retinas compared to normal controls (Figure 7B). Treatment
with  CBD  blocked  uveitis-induced  oxidative  stress  as
indicated  by  significant  inhibition  of  fluorescence
accumulation  in  these  retinas.  We  further  confirmed  the
antioxidant effects of CBD by measuring tyrosine nitration.
As shown in Figure 7C, images from uveitic retinas of 6 rats
showed significant tyrosine nitration within retinal layers with
strongest  immunoreactivity  within  the  plexiform  layers.
Quantitative analysis showed that levels of tyrosine nitration
were increased 2.8 fold in the uveitic retinas in comparison
with  the  controls.  This  tyrosine  nitration  was  almost
completely eliminated by CBD (Figure 7D).
CBD reduces p38 MAPK activation and cell death in the
uveitic retina: Our results in cultured retinal microglial cells
suggest  that  endotoxin-induced  oxidative  stress  induces
retinal inflammation via activation of p38 MAPK. Activated
p38 MAPK is not only an important factor for microglial
activation, it also plays an important role in cell survival and
death. We therefore examined the role of p38 MAPK in uveitic
retinas and determined whether CBD treatment blocks this
pathway. Western blot analysis of the phosphorylation of p38
MAPK  in  uveitic  retinas  showed  an  estimated  1.8  fold
increase at 24 h after LPS injection (Figure 8A). Treatment
with  CBD  significantly  blocked  the  increases  in
phosphorylation of p38 MAPK. Accelerated death of retinal
ganglion cells and neurons has been reported to be significant
in uveitis in vitro [5]. Therefore, we tested the hypothesis that
CBD prevents death of neurons in LPS-induced uveitis in rat
retinas.  Retinal  neuronal  cell  death  was  determined  using
TUNEL-FITC analysis on frozen eye sections and western
Molecular Vision 2008; 14:2190-2203 <http://www.molvis.org/molvis/v14/a256> © 2008 Molecular Vision
2197Figure 7. Cannabidiol reduces oxidative and nitrative stresses in the uveitic retina. A: Cannabidiol (CBD) reduces reactive oxygen species
(ROS) in the retinas of uveitic rats as represented by DCF fluorescence in rat retina. Representative image shows the fluorescence distribution
in different retinal layers (magnification ×100). Abbreviations: Ganglion cell layer (GCL); inner nuclear layer (INL); outer nuclear layer
(ONL). B: Morphometric analysis of fluorescence intensity in serial sections of rat eyes shows that uveitic rats had a significant increase in
fluorescence (1.5-fold) compared with controls. Treatment with CBD (5 mg/kg) inhibited ROS formation in uveitic rats. Data shown is the
mean±SEM of 4-5 animals in each group (asterisk represents that it is significantly different when compared with the controls at p<0.05). C:
CBD reduces nitrotyrosine in the retina of uveitic rats. A representative image shows the nitrotyrosine distribution mainly in the retinal
plexiform layers and outer segments (magnification ×200). D: Morphometric analysis of fluorescence intensity in serial sections of rat eyes
showing that uveitic rats had a significant increase in fluorescence (2.8-fold) compared with controls. Treatment with CBD (5 mg/kg) inhibited
nitrotyrosine formation in the uveitic rats. Data shown is the mean±SEM of 6 animals in each group (asterisk represents that it is significantly
different when compared with the controls at p<0.05).
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2198analysis of retinal caspase-3. As shown in Figure 8B, LPS
administration in rats resulted in the induction of neuronal
death  as  indicated  by  the  significant  number  of  TUNEL
positive cells (green, see white arrows) in the retinal ganglion
cell layer. In these LPS-treated rats, the activated p38 MAPK
was colocalized with TUNEL positive neurons (Figure 8C).
CBD blocked the activation of p38 MAPK and neuronal cell
death in LPS-injected animals. Caspase-3 is an intracellular
cysteine protease that exists as a pro-enzyme and becomes
activated during the cascade of apoptosis. We confirmed LPS-
induced  apoptosis  by  significant  increases  of  cleaved
caspase-3  expression  in  LPS-treated  animals  (Figure  8D).
Treatment  with  5  mg/kg  CBD  significantly  reduced  the
number of TUNEL-positive cells and expression of caspase-3.
DISCUSSION
In  the  present  study,  we  have  demonstrated  that  stress-
activated retinal microglial cells play a key role in mediating
retinal  inflammation.  Using  primary  culture  of  rat  retinal
Figure 8. Cannabidiol reduces p38 MAPK activation and prevents cell death in the uveitic retina. A: Lipopolysaccharide (LPS) treatment of
rats resulted in a significant increase in p38 MAPK activation at 24 h. CBD (5 mg/kg) treatment reduced this effect. Data from 2 animals in
each group are shown (asterisk represents that it is significantly different at p<0.05 as compared to control), Similar results were obtained in
2 independent experiments. B: CBD blocked neuronal cell death, as detected by TUNEL analysis. Data shown is the mean±SEM of 3 animals
in each group (asterisk represents that it is significantly different at p<0.05 as compared to control). C: Colocalization of phospho-p38 MAPK
(red) and TUNEL+cells (green) in the retinal ganglion cell layer. CBD blocked LPS-induced activation of p38 MAPK and blocked neuronal
cell death. D: CBD blocked LPS-induced caspase-3 expression that was detected by Western analysis in the uveitic retina. Data from 2 animals
in each group are shown (asterisk represents that it is significantly different at p<0.05 compared to control). Similar results were obtained in
2 independent experiments.
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2199microglia,  we  have  shown  that  treatment  with  LPS  first
induces oxidative stress, then p38 MAPK activation, leading
to  accumulation  of  TNF-α.  Retinal  inflammation  was
maintained with nitrative stress, another phase of p38 MAPK
activation, and resulted in neurodegeneration. These effects
were blocked by treatment with the nonpsychoactive CBD in
vitro and in vivo. To our knowledge, this is the first work to
study the molecular and cellular processes involved in the
stress-activated  retinal  inflammation  and  the
antiinflammatory and neuroprotective effects of CBD in the
retina.
Inflammatory  retinal  diseases  including  uveitis,
glaucoma, macular degeneration, and diabetic retinopathy are
characterized by microglial activation. Microglial cells are
commonly described as the central nervous system equivalent
of tissue macrophages, which, upon tissue injury, become
activated to release glutamate, ROS, and cytokines, leading to
inflammation, vascular dysfunction, and neurodegeneration
[1]. To test the hypothesis that activated microglia, similar to
those in the injured brain, are present in the retina during
inflammation, we examined the effects of LPS on rat retinas.
Indeed,  there  was  a  dramatic  increase  in  infiltrated
macrophages  in  the  retina  and  serum  levels  of  TNF-α  in
response  to  LPS  injection.  In  agreement,  immune  cells
including macrophages are known to release proinflammatory
cytokines to amplify the inflammatory reactions both locally
and systematically. Moreover, our results showed that LPS-
Figure 9. Schematic figure summarizes the proposed mechanism of
lipopolysaccharide-induced  retinal  degeneration.
Lipopolysaccharide  (LPS)-induced  oxidative  stress  leads  to  p38
MAPK  activation,  tumor  necrosis  factor-α  (TNF-α)  release,  and
another phase of p38 MAPK activation. The autoregulatory loop of
TNF-α release and oxidative stress leads to microglial activation and
retinal neurodegeneration. Suggested sites where cannabidiol (CBD)
blocks this pathway are indicated.
treated  microglial  cells  exhibited  significant  increases  in
TNF-α and NO levels, indicating that retinal microglial cells
provide  a  feasible  model  for  studying  the  molecular
mechanism and the role of microglia in mediating retinal
inflammation. In addition, the use of primary culture of retina
microglia offers the advantage of studying the response of a
pure population of microglia to controlled and designated
treatments.
Using primary culture of rat retinal microglial cells, we
showed that treatment with low levels of LPS induced an
immediate  and  significant  increase  in  superoxide  anion
formation which was blocked by treatment with 1 μM CBD.
To identify the source of superoxide anion formation, we
compared  the  antioxidant  effects  of  CBD  with  TTFA,  an
inhibitor of mitochondrial oxidase or apocynin, an inhibitor
of NADPH oxidase. The results showed comparable effects
of CBD to apocynin in inhibiting superoxide anion formation.
However, TTFA did not prevent superoxide anion formation
in LPS-treated cells. Together, these results suggest that in
response to LPS, activation of NADPH oxidase is a major
source of superoxide anion. In agreement, other studies have
shown that microglial NADPH oxidase is a major source of
ROS formation in the LPS model of inflammation [6,19,20].
The antioxidant effects of CBD have been attributed to its
ability  to  directly  scavenge  ROS  [10].  However,  this
scavenging activity requires higher levels of CBD (2.5–5 μM)
[21]. Thus, the antioxidant effects of CBD at 1 μM could be
at least partially attributed to its effects in inhibiting NADPH
oxidase  activity  rather  than  entirely  ascribed  to  ROS
scavenging activity.
The receptor mainly responsible for LPS recognition is
the toll-like receptor 4 (TLR4), which triggers a variety of
intracellular signaling cascades, including MAPK cascade,
leading  to  the  induction  of  transcription  of  target  genes
involved in the innate immune response [19]. Therefore, we
examined the effects of LPS on p38 MAPK activation in
cultured microglial cells. Our results showed an early (30 min)
and time-dependent effect of LPS in activating p38 MAPK,
which  was  blocked  by  treatment  with  CBD  or  apocynin
(Figure 5A). These experiments have clearly demonstrated the
causal  relationship  of  oxidative  stress  and  p38  MAPK
activation.
Activation of p38 MAPK has been recognized as a major
event involving MAPK in the signaling cascade of TNF-α
induction in stimulated macrophages and cerebral microglia
[7,9]. In agreement, our results showed that LPS treatment
induced a time-dependent induction of TNF-α release that
peaked after 6 h and was reduced by specific inhibitors of p38
MAPK (10 μM SB203580) and NADPH oxidase (200 µM
apocynin). Furthermore, we demonstrate that LPS-induced
release  of  TNF-α  release  is  blocked  almost  totally  by
treatment with 1 µM CBD, clearly showing that CBD exerts
more potent effects than apocynin or SB203580.
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production of NO have been implicated as a mechanism by
which activated microglia kill neurons [22]. Therefore, we
investigated the effects of LPS on NO production in cultured
microglial cells. Our results showed significant and dramatic
increases in NO after 6–12 h but not at the early phase of LPS
treatment (0–30 min). This effect was in parallel with a second
wave of increased formation of ROS and peroxynitrite as
indicated by increased DCF fluorescence and nitrotyrosine
levels in vitro and in vivo. The late phase effects of LPS were
prevented by CBD treatment in cultured microglial cells and
in vivo. p38 MAPK, a stress-activated protein kinase, is a
downstream target of proinflammatory cytokines including
TNF-α [23] and oxidative stress [18]. The activation of p38
MAPK  has  been  described  to  induce  transcription-
independent effects such as induction of actin reorganization
and cellular motility [8]. In agreement, our results showed
increased expression and redistribution of F-actin in LPS-
activated microglia (Figure 2E) within the same time frame
as late phase activation of p38 MAPK after 6 h (Figure 6C).
Our  findings  indicate  a  biphasic  pattern  of  p38  MAPK
activation, including an early phase (30–60 min) and a late
phase (2–6 h). This suggests that the first phase occurs as a
result of oxidative stress to induce cytokine release and the
second phase is induced by TNF-α stimulation and maintained
by ROS formation, forming the autoregulatory loop of TNF-
α, sustaining its own biosynthesis. Similar observations for
p38  MAPK  have  been  reported  after  stimulation  with
cytokines or vasoactive agents [24-26]. Figure 9 illustrates the
pathways of LPS-induced oxidative stress leading to TNF-α
release, biphasic p38 MAPK, and microglial activation as well
as the mechanism by which CBD blocks these processes.
The anti-inflammatory effect of CBD is not mediated by
the known cannabinoid receptors because CBD does not bind
well to these receptors. Here, we show that CBD blocks retinal
inflammation  and  microglia  activation  via  inhibition  of
NADPH  oxidase  activity  and  early  p38  MAPK
phosphorylation, resulting in blocking TNF-α release. The
superior effect of CBD over inhibitors of NADPH oxidase and
p38 MAPK could be due to modulation of microglial activity
by inhibiting an unidentified cannabinoid receptor [27], or by
enhancing  endogenous  adenosine  signaling  [28].  Ongoing
studies by our group are in progress to further elucidate the
role of adenosine signaling in the anti-inflammatory effect of
CBD in models of retinal inflammation.
Our results have demonstrated a critical role of oxidative
stress in activating microglial cells and causing inflammation
in  vitro.  To  determine  the  consequences  of  such  cellular
events  in  vivo,  we  determined  steady-state  levels  of
inflammatory  and  oxidative  stress  markers  in  relation  to
retinal neuronal death. The neural retina has a high content of
polyunsaturated fatty acids and hence is extremely susceptible
to oxidative and nitrative insults [29]. NO and peroxynitrite
formation have been reported to play a critical role in the
pathogenesis of LPS-induced uveitis [30]. In agreement, our
results showed a 1.5 fold increase in oxidative stress and a 2.8
fold increase in peroxynitrite formation as indicated by DCF
fluorescence and nitrotyrosine, respectively (Figure 7). These
effects were associated with increased inflammation (Figure
1),  p38  MAPK  activation,  and  retinal  neurodegeneration
(Figure 8). Similarly, accelerated death of retinal cells has
been reported in rats after LPS treatment [31]. These results
confirm our findings that LPS-induced oxidative and nitrative
stress  activate  microglial  cells,  which  causes  neuronal
degeneration. Our present finding that CBD blocked oxidative
and  nitrative  stress,  macrophage  infiltration,  TNF-α
production, and prevented retinal neurodegeneration suggest
that CBD represents novel therapeutics in the treatment of
inflammation-mediated retinal damage. Furthermore, CBD is
an attractive medical alternative to smoked marijuana or plant
extract because of its lack of psychoactive effect [32] and is
well  tolerated  in  humans  [33].  In  conclusion,  the  data
presented here provide evidence that stress-activated retinal
microglial cells and their inactivation by CBD represent a
central player in retinal inflammation and neuroprotection,
respectively.
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